22 July 2019

Amedeo Smart

Independent Medical Education

Subscriber: th..@boehringer-ingelheim.com

HIV Infection

22 July 2019 | n=37

  1. Fleming J, Mathews WC, Rutstein RM, Aberg J, et al.
    Low level viremia and virologic failure in persons with HIV infection treated with antiretroviral therapy.
    AIDS 2019.

  2. Dell'acqua R, Galli L, Poli A, Mastrangelo A, et al.
    Viro-immunological outcomes after thirteen-valent pneumococcal vaccination in HIV-1 infected subjects on stable virological suppression.
    AIDS 2019.

  3. Patel RC, Stalter RM, Thomas KK, Tamraz B, et al.
    A pharmacokinetic and pharmacogenetic evaluation of contraceptive implants and antiretroviral therapy among women in Kenya and Uganda.
    AIDS 2019.

  4. Teasdale CA, Yuengling KA, Mutiti A, Arpadi S, et al.
    Delays in fast track ART initiation and reasons for not starting treatment among eligible children in Eastern Cape, South Africa.
    AIDS 2019.

  5. Durier C, Desaint C, Lelievre JD, Silbermann B, et al.
    Long-term safety and vaccine-induced seropositivity in healthy volunteers from HIV vaccine trials: a French cohort study.
    AIDS 2019.

  6. Palanee-Phillips T, Brown ER, Szydlo D, Matovu Kiweewa F, et al.
    Risk of HIV-1 acquisition among South African women using a variety of contraceptive methods in a prospective study.
    AIDS 2019;33:1619-1622.

  7. Faurholt-Jepsen D, Olsen MF, Andersen AB, Kaestel P, et al.
    Hyperglycemia and insulin function in antiretroviral treatment-naive HIV patients in Ethiopia: a potential new entity of diabetes in HIV?
    AIDS 2019;33:1595-1602.

  8. Grossman MA, Hofmann C, Ng HL, Yang OO, et al.
    Suboptimal stimulation by weak agonist epitope variants does not drive dysfunction of HIV-1-specific cytotoxic T lymphocyte clones.
    AIDS 2019;33:1565-1574.

  9. Kearns AC, Velasquez S, Liu F, Dai S, et al.
    Elevated indoleamine-2,3-dioxygenase enzyme activity in a novel mouse model of HIV-associated atherosclerosis.
    AIDS 2019;33:1557-1564.

  10. Cappelletti A, Peri AM, Bisi L, Sabbatini F, et al.
    Recurrent posterior reversible encephalopathy syndrome in an HIV-HCV coinfected liver transplant recipient.
    AIDS 2019;33:1679-1681.

  11. Flynn PM, Abrams EJ.
    Response to correspondence entitled: Perinatal HIV and response to vaccination.
    AIDS 2019;33:1675-1677.

  12. Dauby N.
    Perinatal HIV and response to vaccination.
    AIDS 2019;33:1674-1675.

  13. Rizzardo S, Lanzafame M, Lattuada E, Luise D, et al.
    Dolutegravir monotherapy and body weight gain in antiretroviral naive patients.
    AIDS 2019;33:1673-1674.

  14. Pantazis N, Papastamopoulos V, Paparizos V, Metallidis S, et al.
    Long-term evolution of CD4+ cell count in patients under combined antiretroviral therapy.
    AIDS 2019;33:1645-1655.

  15. Shroufi A, Van Cutsem G, Cambiano V, Bansi-Matharu L, et al.
    Simplifying switch to second-line antiretroviral therapy in sub Saharan Africa: predicted effect of using a single viral load to define efavirenz-based first-line failure.
    AIDS 2019;33:1635-1644.

  16. Morgello S, Gensler G, Sherman S, Ellis RJ, et al.
    Frailty in medically complex individuals with chronic HIV.
    AIDS 2019;33:1603-1611.

  17. Rizzardini G, Gori A, Miralles C, Olalla J, et al.
    Randomized study evaluating the efficacy and safety of switching from an an abacavir/lamivudine-based regimen to an elvitegravir/cobicistat/emtricitabine/tenofovir alafenamide single-tablet regimen.
    AIDS 2019;33:1583-1593.

  18. Tzou PL, Rhee SY, Shafer R.
    Amino Acid Prevalence of HIV-1 pol Mutations by Direct PCR and Single Genome Sequencing.
    AIDS Res Hum Retroviruses 2019.

  19. Paolillo EW, Saloner R, Montoya JL, Campbell LM, et al.
    Frailty in Comorbid HIV and Lifetime Methamphetamine Use Disorder: Associations with Neurocognitive and Everyday Functioning.
    AIDS Res Hum Retroviruses 2019.

  20. Taramasso L, Bozzi G, Muscatello A, Bandera A, et al.
    Immunonutrition in Human Immunodeficiency Virus Infection: Which Populations to Target?
    Clin Infect Dis 2019.

  21. Drain PK, Kubiak RW, Siriprakaisil O, Klinbuayaem V, et al.
    confUrine Tenofovir Concentrations Correlate with Plasma and Relates to TDF Adherence: A Randomized Directly-observed Pharmacokinetic Trial (TARGET Study).
    Clin Infect Dis 2019.

  22. Lynch C, Green S, Lewis N, Megson C, et al.
    Neurologic symptomatic cryptococcal antigenaemia in a patient with well-controlled HIV.
    Clin Infect Dis 2019.

  23. Li T, Ju E, Gao SJ.
    Kaposi sarcoma-associated herpesvirus miRNAs suppress CASTOR1-mediated mTORC1 inhibition to promote tumorigenesis.
    J Clin Invest 2019;130.

  24. Spudich S, Robertson KR, Bosch RJ, Gandhi RT, et al.
    Persistent HIV-infected cells in cerebrospinal fluid are associated with poorer neurocognitive performance.
    J Clin Invest 2019;130.

  25. Clifford DB.
    Is successful HIV therapy a Pyrrhic victory for the brain?
    J Clin Invest 2019;130.

  26. Nabatanzi R, Bayigga L, Cose S, Rowland Jones S, et al.
    Monocyte Dysfunction, Activation, and Inflammation After Long-Term Antiretroviral Therapy in an African Cohort.
    J Infect Dis 2019.

  27. Mozhgani SH, Ghobadi MZ, Rad MB, Farzanehpour M, et al.
    Reconnaissance of candidate genes involved in human immunodeficiency virus (HIV) pathogenesis and targeted by antiretroviral therapy.
    J Med Virol 2019.

  28. Qian W, Miner CA, Ingle H, Platt DJ, et al.
    A human STAT1 gain-of-function mutation impairs CD8(+) T cell responses against gammaherpesvirus-68.
    J Virol 2019.

  29. Yero A, Farnos O, Rabezanahary H, Racine G, et al.
    Differential dynamics of regulatory T-cell (Treg) and Th17 cell balance in mesenteric lymph nodes and blood following early anti-retroviral initiation during acute SIV infection.
    J Virol 2019.

  30. Headley J, Gustav R, Kavanagh MM, Mworeko L, et al.
    Leading UNAIDS: a once-in-a-generation challenge?
    Lancet 2019.

  31. Wei X, Nielsen R.
    CCR5-32 is deleterious in the homozygous state in humans.
    Nat Med 2019;25:909-910.

  32. Abdool Karim SS.
    HIV-1 Epidemic Control - Insights from Test-and-Treat Trials.
    N Engl J Med 2019;381:286-288.

  33. Makhema J, Wirth KE, Pretorius Holme M, Gaolathe T, et al.
    Universal Testing, Expanded Treatment, and Incidence of HIV Infection in Botswana.
    N Engl J Med 2019;381:230-242.

  34. Havlir DV, Balzer LB, Charlebois ED, Clark TD, et al.
    HIV Testing and Treatment with the Use of a Community Health Approach in Rural Africa.
    N Engl J Med 2019;381:219-229.

  35. Hayes RJ, Donnell D, Floyd S, Mandla N, et al.
    Effect of Universal Testing and Treatment on HIV Incidence - HPTN 071 (PopART).
    N Engl J Med 2019;381:207-218.

  36. Pinzon-Charry A, Wallace G, Clark JE, Nourse C, et al.
    Anti-NMDA-receptor Encephalitis in an Adolescent With HIV Infection and Review of the Literature.
    Pediatr Infect Dis J 2019;38:e169-e171.

  37. Wise J.
    Global effort to reduce new HIV infections is stalling, UN warns.
    BMJ 2019;366:l4744.

Display articles in

Amedeo HIV Infection

Data Origin

You selected the following journals for your Amedeo HIV Infection newsletter:

AIDS, AIDS Res Hum Retroviruses, Ann Intern Med, BMJ, Clin Infect Dis, J Acquir Immune Defic Syndr, J Clin Immunol, J Clin Invest, J Infect Dis, J Med Virol, J Virol, JAMA, Lancet, N Engl J Med, Nat Med, Pediatr Infect Dis J, Science, Virology.

To modify the journal selection, please open your Newsletter Management Page. If you don't remember the URL, please submit the email address of your Amedeo subscription.

Your email:

Amedeo HIV Infection

Five-Week Literature

09 December 2019

02 December 2019

25 November 2019

21 November 2019

11 November 2019

22 July 2019

Multidisciplinary Journal Club

  1. Utjes D, Malmstedt J, Teras J, Drzewiecki K, et al.
    2-cm versus 4-cm surgical excision margins for primary cutaneous melanoma thicker than 2 mm: long-term follow-up of a multicentre, randomised trial.
    Lancet. 2019 Jul 4. pii: S0140-6736(19)31132.

  2. Laplaud DA, Casey R, Barbin L, Debouverie M, et al.
    Comparative effectiveness of teriflunomide vs dimethyl fumarate in multiple sclerosis.
    Neurology. 2019 Jul 12. pii: WNL.0000000000007938.

  3. Martin NK, Jansen K, An der Heiden M, Boesecke C, et al.
    Can HCV be eliminated among HIV-positive men who have sex with men in Berlin? A modeling analysis.
    J Infect Dis. 2019 Jul 12. pii: 5532024. doi: 10.1093.

Every week, Amedeo's Multidisciplinary Journal Club (MJC) presents a selection of outstanding articles. Take a look beyond the horizon.

Free Medical Abstracts
Privacy Policy

© Amedeo 1997-2016